Abstract：
OBJECTIVE:To evaluate the feasibility and intermediate-term results of a short course of high-dose-rate (HDR) intravaginal brachytherapy only after hysterectomy. METHODS AND MATERIALS:From December 1999 to February 2005, 50 patients with International federation of gynecology and obstetrics Stages IA-IIB endometrioid endometrial adenocarcinoma were treated with total abdominal hysterectomy and bilateral salpingo-oophorectomy followed by postoperative HDR brachytherapy alone. The mean age of the patients was 62.6 years (range 42-86). International federation of gynecology and obstetrics patient grouping included IaG3N(x) (n=1), IbG1N(0) (n=1), IbG1N(x) (n=2), IbG2N(0) (n=10), IbG2N(x) (n=20), IbG3N(0) (n=3), IbG3N(x) (n=1), IcG1N(x) (n=2), IcG2N(0) (n=3), IcG3N(0) (n=3), IIaG1N(x) (n=2), IIaG2N(x) (n=1), and IIbG1N(0) (n=1). Twenty-one patients (42.0%) had been surgically staged. Four to 16 weeks after surgery (median 42d, range 28-112), all patients received HDR intravaginal brachytherapy to 25Gy in five consecutive 5-Gy daily fractions prescribed at 0.5-cm depth. Median HDR brachytherapy treatment duration was 5 days (range 5-12). RESULTS:After a median followup of 37 months (range 12-80), the overall survival and disease-free survival were 96%. No vaginal or pelvic recurrences have been observed. One patient (2%) developed distant metastases. No late toxicities of Grade 3 or greater have been reported. CONCLUSIONS:The results reported in this study are in agreement with previous reports of postoperative HDR brachytherapy alone in early-stage endometrial cancer. HDR brachytherapy alone seems to provide adequate tumor control. The fractionation schedule proposed (25Gy in five consecutive daily treatments) was well tolerated and is convenient for patients living far from the radiation center.
journal_name
Brachytherapyjournal_title
Brachytherapyauthors
Martínez-Monge R,Nagore G,Cambeiro M,Garrán C,Villafranca E,Jurado Mdoi
10.1016/j.brachy.2007.04.001subject
Has Abstractpub_date
2007-07-01 00:00:00pages
195-200issue
3eissn
1538-4721issn
1873-1449pii
S1538-4721(07)00208-5journal_volume
6pub_type
杂志文章相关文献
Brachytherapy文献大全abstract：PURPOSE:GammaTile cesium-131 (131Cs) permanent brain implant has received Food and Drug Administration (FDA) clearance as a promising treatment for certain brain tumors. Our center was the first institution in the United States after FDA clearance to offer the clinical use of GammaTile brachytherapy outside of a clinic...
journal_title：Brachytherapy
pub_type： 杂志文章
doi：10.1016/j.brachy.2020.12.005
更新日期：2021-01-21 00:00:00
abstract：PURPOSE:To quantify needle migration and dosimetric impact in high-dose-rate brachytherapy for prostate cancer and propose a threshold for needle migration. METHODS AND MATERIALS:Twenty-four high-risk prostate cancer patients treated with an HDR boost of 2 × 8.5 Gy were included. Patients received an MRI for planning ...
journal_title：Brachytherapy
pub_type： 杂志文章
doi：10.1016/j.brachy.2017.08.005
更新日期：2018-01-01 00:00:00
abstract：BACKGROUND:To determine the feasibility of combined perioperative high-dose-rate brachytherapy (PHDRB) and intermediate-dose external beam radiation therapy (EBRT) as an alternative to full-dose adjuvant EBRT in patients with unirradiated squamous cell cancer (SCC) of the oral cavity and oropharynx. METHODS AND MATERI...
journal_title：Brachytherapy
pub_type： 杂志文章
doi：10.1016/j.brachy.2008.10.002
更新日期：2009-01-01 00:00:00
abstract：UNLABELLED:PURPOSE/INTRODUCTION: To safely irradiate retroperitoneal targets as paraaortic lymph node by separating abdominal at-risk organs from the target during irradiation, we created a percutaneous paravertebral approach of high-dose-rate brachytherapy with hyaluronate gel injection (HGI). We report a case treated...
journal_title：Brachytherapy
pub_type： 杂志文章
doi：10.1016/j.brachy.2011.12.004
更新日期：2013-01-01 00:00:00
abstract：PURPOSE:To compare a standard radio-oncological and a surgical biochemical failure definition after combined-modality radiation therapy (CRT) in men with intermediate- and high-risk prostate cancer. METHODS:425 men were treated with external beam radiotherapy (59.4 Gy, 33 fractions) and 125J seed-brachytherapy (S-BT, ...
journal_title：Brachytherapy
pub_type： 杂志文章
doi：10.1016/j.brachy.2019.09.001
更新日期：2020-01-01 00:00:00
abstract：PURPOSE:To evaluate the efficacy and side effect profile of adjuvant vaginal vault brachytherapy alone after hysterectomy in Stage I endometrial carcinoma. METHODS AND MATERIALS:Between 23/11/1992 and 16/05/2005, a total of 173 patients with early endometrial carcinoma treated with vaginal vault brachytherapy alone po...
journal_title：Brachytherapy
pub_type： 杂志文章
doi：10.1016/j.brachy.2008.01.001
更新日期：2008-04-01 00:00:00
abstract：PURPOSE:There is strong evidence relating postimplant dosimetry for low-dose-rate prostate seed brachytherapy to local control rates. The delineation of the prostate on CT images, however, represents a challenge due to the lack of soft-tissue contrast to identify the prostate borders. This study aims at quantifying the...
journal_title：Brachytherapy
pub_type： 杂志文章
doi：10.1016/j.brachy.2016.08.013
更新日期：2016-01-01 00:00:00
abstract：PURPOSE:The purpose of this study was to prospectively assess the variations in health-related quality of life (HR-QoL) in patients who underwent low-dose rate prostate brachytherapy using iodine-125 seed source during the first year after seed implantation. METHODS AND MATERIALS:Between July 2004 and December 2006, 1...
journal_title：Brachytherapy
pub_type： 杂志文章
doi：10.1016/j.brachy.2009.07.013
更新日期：2010-10-01 00:00:00
abstract：PURPOSE:This is a retrospective review of our experience using high-dose-rate (HDR) brachytherapy boost for prostate cancer. METHODS AND MATERIALS:During the study period, we recommended external beam radiotherapy (45 Gy) and HDR boost (18 Gy in three fractions) combined with hormonal therapy (HT) for 2 months before ...
journal_title：Brachytherapy
pub_type： 杂志文章
doi：10.1016/j.brachy.2005.03.005
更新日期：2005-01-01 00:00:00
abstract：PURPOSE:The American Brachytherapy Society (ABS) consensus guidelines for high-dose-rate (HDR) prostate brachytherapy suggest 11 different dose constraints for the urethra. The purpose of this study is to evaluate whether a single urethral constraint of D0.1 cm3 < 110% could meet all the proposed ABS urethral constrain...
journal_title：Brachytherapy
pub_type： 杂志文章
doi：10.1016/j.brachy.2019.12.001
更新日期：2020-01-01 00:00:00
abstract：PURPOSE:To assess the feasibility and tumor outcome of re-irradiation with low-dose-rate brachytherapy for macroscopic local recurrences after radical prostatectomy (RP) followed by adjuvant or salvage external beam radiation therapy (EBRT). METHODS AND MATERIALS:Between 2011 and 2018, five men with histologically pro...
journal_title：Brachytherapy
pub_type： 杂志文章
doi：10.1016/j.brachy.2020.07.001
更新日期：2021-01-01 00:00:00
abstract：PURPOSE:The aim of the study was to evaluate the results of high-dose-rate interstitial brachytherapy (HDR-ISBT) for patients with advanced cervical carcinoma in which intracavitary radiation therapy may result in a suboptimal dose distribution. METHODS AND MATERIALS:Between 1995 and 2005, 25 patients of median age 64...
journal_title：Brachytherapy
pub_type： 杂志文章
doi：10.1016/j.brachy.2008.12.002
更新日期：2009-04-01 00:00:00
abstract：PURPOSE:In July 2009, American Society of Radiation Oncology (ASTRO) released a consensus statement (CS) to guide patient selection for accelerated partial breast irradiation (APBI). The goal of this study was to examine how practice patterns changed following the guideline's release. METHODS:The Surveillance, Epidemi...
journal_title：Brachytherapy
pub_type： 杂志文章
doi：10.1016/j.brachy.2015.03.003
更新日期：2015-07-01 00:00:00
abstract：PURPOSE:Although surgery remains a treatment option for symptomatic brain metastases, the need for adjuvant radiation after surgery is widely accepted as standard. Despite a multitude of randomized trials aimed at identifying the ideal radiation treatment plan for surgically resected metastases, the development of new ...
journal_title：Brachytherapy
pub_type： 杂志文章
doi：10.1016/j.brachy.2020.11.004
更新日期：2021-01-13 00:00:00
abstract：PURPOSE:Stereotactic body radiotherapy (SBRT) is being used with increasing frequency as definitive treatment of early stage prostate cancer. Much of the justification for its adoption was derived from earlier clinical results using high-dose-rate (HDR) brachytherapy. We determine whether HDR's dosimetry can be achieve...
journal_title：Brachytherapy
pub_type： 临床试验,杂志文章
doi：10.1016/j.brachy.2013.03.003
更新日期：2013-09-01 00:00:00
abstract：PURPOSE:The purpose of this study was to evaluate the incidence of late severe (≥Grade 3) urinary toxicity and the long-term efficacy after low-dose-rate brachytherapy (LDR-BT) in patients with localized prostate cancer (PCa). METHODS AND MATERIALS:During the years 1999-2008, 241 patients with PCa who underwent LDR-BT...
journal_title：Brachytherapy
pub_type： 杂志文章
doi：10.1016/j.brachy.2019.05.005
更新日期：2019-01-01 00:00:00
abstract：PURPOSE:To provide an MRI based functional anatomy guide to prostate brachytherapy. METHODS AND MATERIALS:We performed a narrative review of periprostatic functional anatomy and the significance of this anatomy in prostate brachytherapy treatment planning. RESULTS:MRI has improved delineation of gross tumor and criti...
journal_title：Brachytherapy
pub_type： 杂志文章
doi：10.1016/j.brachy.2016.11.009
更新日期：2017-01-01 00:00:00
abstract：PURPOSE:To analyze the dosimetric impact and periprocedural outcomes with a bioabsorbable hydrogel rectal spacer injected during low-dose-rate (LDR) prostate brachytherapy implants. METHODS AND MATERIALS:A consecutive series of 80 patients implanted with stranded I-125 LDR brachytherapy seeds were evaluated, of which ...
journal_title：Brachytherapy
pub_type： 杂志文章
doi：10.1016/j.brachy.2019.11.002
更新日期：2020-01-01 00:00:00
abstract：PURPOSE:Treatment of locally advanced cervical cancer in patients with a renal graft requires precautions. The graft is usually in a pelvic position, close to the clinical target volume (CTV). Preserving the graft while ensuring local control is a challenge we have faced in two occasions. We report our experience. MET...
journal_title：Brachytherapy
pub_type： 社论
doi：10.1016/j.brachy.2013.11.003
更新日期：2014-01-01 00:00:00
abstract：PURPOSE:Currently, there are high dose rate afterloaders available that can drive two different radioactive sources simultaneously. The source-source and source-cable attenuations are not taken into account by current planning systems. The purpose of this work is to characterize these effects and their overall impact o...
journal_title：Brachytherapy
pub_type： 杂志文章
doi：10.1016/j.brachy.2016.03.007
更新日期：2016-07-01 00:00:00
abstract：:A 17-year-old girl diagnosed with a previously irradiated, locally recurrent Ewing's sarcoma involving the puboischiatic rami and the adjacent acetabulum was referred to our institution for consideration of salvage hindquarter resection. A conservative resection with implantation of the acetabular remnant for high-dos...
journal_title：Brachytherapy
pub_type： 杂志文章
doi：10.1016/S1538-4721(03)00098-9
更新日期：2003-01-01 00:00:00
abstract：PURPOSE:The aim of this work was to analyze the results of palliative HDR brachytherapy in patients with advanced esophageal cancer. METHODS AND MATERIALS:Ninety-one patients with unresectable, advanced esophageal cancer were treated palliatively by HDR brachytherapy. All patients received a total dose of 22.5 Gy in t...
journal_title：Brachytherapy
pub_type： 临床试验,杂志文章
doi：10.1016/j.brachy.2004.05.003
更新日期：2004-01-01 00:00:00
abstract：PURPOSE:To quantify the percentage doses received by salivary glands (SGDs) in head and neck interstitial brachytherapy (BT). METHODS AND MATERIALS:The study included 43 patients who underwent high-dose rate iridium-192 implant for oral cavity and oropharyngeal lesions treated with BT as a boost. BT dose varied with d...
journal_title：Brachytherapy
pub_type： 杂志文章
doi：10.1016/j.brachy.2010.03.001
更新日期：2011-01-01 00:00:00
abstract：BACKGROUND AND PURPOSE:Esophageal neoplasm has a poor prognosis, and palliative care remains an important goal of treatment. The purpose of this study was to assess the ability of high-dose-rate brachytherapy (HDRB) to improve dysphagia in 115 patients treated at our institution. METHODS AND MATERIALS:Patients previou...
journal_title：Brachytherapy
pub_type： 杂志文章
doi：10.1016/j.brachy.2014.09.007
更新日期：2015-01-01 00:00:00
abstract：PURPOSE:Determine whether fat distribution, body mass index, or clinical and dosimetric factors are associated with prostate specific antigen (PSA) bounce (PSAb) of ≥1.6 ng/mL in patients treated with permanent seed (125)I prostate brachytherapy (PB). METHODS AND MATERIALS:We identified 23 patients with a PSAb of ≥1.6...
journal_title：Brachytherapy
pub_type： 杂志文章
doi：10.1016/j.brachy.2013.05.005
更新日期：2013-11-01 00:00:00
abstract：PURPOSE:Dose escalation has been shown beneficial in prostate cancer. Brachytherapy (BT) provides an opportunity for dose escalation beyond what can be safely delivered using only teletherapy methods. The purpose of this study was to determine cancer control and morbidity of external beam radiation therapy (EBRT) plus ...
journal_title：Brachytherapy
pub_type： 杂志文章
doi：10.1016/j.brachy.2009.01.002
更新日期：2009-04-01 00:00:00
abstract：PURPOSE:The aim of this work was to analyze the exposure rates measured in the proximity of patients who underwent prostate low-dose-rate brachytherapy with I-125 implant. Effective doses to relatives and to population were computed to estimate the time to reach radioprotection dose constraints. METHODS AND MATERIALS:...
journal_title：Brachytherapy
pub_type： 杂志文章
doi：10.1016/j.brachy.2020.09.003
更新日期：2021-01-01 00:00:00
abstract：PURPOSE:We sought to develop an activity nomogram for magnetic resonance (MR)-planned permanent seed prostate brachytherapy to improve quality assurance through a secondary dosimetric check. METHODS AND MATERIALS:Patients undergoing MRI-assisted radiosurgery (MARS), whereby MRI is used for preoperative planning and po...
journal_title：Brachytherapy
pub_type： 杂志文章
doi：10.1016/j.brachy.2019.10.002
更新日期：2020-01-01 00:00:00
abstract：PURPOSE:To improve efficiency, convenience, and cost, a prospective phase II trial was initiated to evaluate accelerated partial breast irradiation delivered with noninvasive image-guided breast brachytherapy (NIBB) via five once-daily fractions. METHODS AND MATERIALS:Women ≥50 years old with early-stage breast cancer...
journal_title：Brachytherapy
pub_type： 杂志文章,多中心研究,随机对照试验
doi：10.1016/j.brachy.2018.05.006
更新日期：2018-01-01 00:00:00
abstract：PURPOSE:To evaluate the long-term disease control and toxicity to the organs at risk after dose-escalated image-based adaptive brachytherapy (BT) in cervical cancer. METHODS AND MATERIALS:Sixty patients of cervical cancer were treated with external radiotherapy 46 Gy in 23 fractions with weekly cisplatin and MRI-guide...
journal_title：Brachytherapy
pub_type： 杂志文章
doi：10.1016/j.brachy.2017.09.008
更新日期：2018-01-01 00:00:00
